Godavari Drugs Ltd (530317) — Board Meeting | 1 September 2026
Godavari Drugs announced board approval to amend its memorandum to add a new business objective for nutraceuticals and dietary supplements, requiring shareholder approval via special resolution at the upcoming 38th AGM on 25 September 2026. The amendment is additive and does not affect existing operations.
About Godavari Drugs Ltd (530317)
Healthcare · Pharmaceuticals · Listed on BSE
📡 Get AI alerts when 530317 files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track 530317 — Free💡 Ask AI about this filing
📊 More 530317 filings
- 🟡 Board Meeting — 31 August 2026 Godavari Drugs approved altering its memorandum to add nutraceuticals and dietary supplements as a n...
🔥 Also filed on 1 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts for your stocks — summarized by AI daily
Set up your AI Radar — pick stocks, get daily email summaries of new filings.
Set up AI Radar — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research
About · Privacy Policy · Terms of Service · Pricing
Today's Announcements · Screener · Insights · AI Chat
Data provided by CMOTS Internet Technologies Pvt Ltd